Lv11
40 积分 2024-09-11 加入
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
2小时前
待确认
Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer
2个月前
已完结
Targeting the deubiquitinase USP7 for degradation with PROTACs
2个月前
已完结
Discovery of a Potent and Selective Degrader for USP7
2个月前
已完结
Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In Vivo Antitumor Immunity Activity against Colon Cancer
2个月前
已完结
皖公网安备34019202002308
